First Quarter 2018 Investor Presentation

Investor Presentation First three months of 2018 Slide 98 Solid sales growth driven by diabetes care Reported annual sales 2013-2017 Reported annual sales split by region DKK billion North America Diabetes Biopharmaceuticals Region China Region Europe Region J&K Region AAMEO Region LATAM 120 100 CAGR¹ 7.5% 17% 20% 3% 3% 6% 5% 9% 10% 21% 11% 11% 80 21% 22% 19% 83% 24% 60 80% 79% 79% 40 78% 47% 52% 20 0 2013 2014 2015 2016 2017 2013 2017 1 CAGR for 5-year period changing diabetes AAMEO: Africa, Asia, Middle-East and Oceania; J&K: Japan and Korea; LATAM: Latin America novo nordisk

View entire presentation